Elena Tsourdi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Postmenopausal Women

Coronavirus Disease

Monoclonal Antibody

Bone Mineral Density

Top Venues

Current osteoporosis reports

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

European journal of endocrinology

The Journal of clinical endocrinology and metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Athanasios D Anastasilakis, Maria P Yavropoulou, Andrea Palermo, Polyzois Makras, Julien Paccou, Gaia Tabacco, Anda Mihaela Naciu, Elena Tsourdi
Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when? European journal of endocrinology 191 (1) (2024)
Athanasios D Anastasilakis, Maria P Yavropoulou, Andrea Palermo, Polyzois Makras, Julien Paccou, Gaia Tabacco, Anda Mihaela Naciu, Elena Tsourdi
Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when. European journal of endocrinology (2024)
Elena Tsourdi
Drug holidays with bisphosphonates in osteoporosis treatment: one size does not fit all. The Journal of clinical endocrinology and metabolism (2024)
Eva Maria Wölfel, Franziska Lademann, Haniyeh Hemmatian, Stéphane Blouin, Phaedra Messmer, Lorenz C Hofbauer, Björn Busse, Martina Rauner, Katharina Jähn, Elena Tsourdi
Reduced Bone Mass and Increased Osteocyte Tartrate-Resistant Acid Phosphatase (TRAP) Activity, But Not Low Mineralized Matrix Around Osteocyte Lacunae, Are Restored After Recovery From Exogenous Hyperthyroidism in Male Mice. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (2022)
Anne Sophie Koldkjær Sølling, Elena Tsourdi, Torben Harsløf, Bente Lomholt Langdahl
Denosumab Discontinuation. Current osteoporosis reports 21 (1) (2022)
Anne Sophie Koldkjær Sølling, Elena Tsourdi, Torben Harsløf, Bente Lomholt Langdahl
Denosumab Discontinuation. Current osteoporosis reports 21 (1) (2022)
Elena Tsourdi, Matthew T Drake
Pros and Cons of Skeletal Medications in the COVID-19 Era. Current treatment options in rheumatology 8 (3) (2022)
Anne Sophie Koldkjær Sølling, Elena Tsourdi, Torben Harsløf, Bente Lomholt Langdahl
Denosumab Discontinuation. Current osteoporosis reports 21 (1) (2022)
Elena Tsourdi
RANKL blockade for cancer cachexia; a new therapeutic opportunity? Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 37 (3) (2022)
Anne Sophie Koldkjær Sølling, Elena Tsourdi, Torben Harsløf, Bente Lomholt Langdahl
Denosumab Discontinuation. Current osteoporosis reports (2022)
Ralf Oheim, Elena Tsourdi, Lothar Seefried, Gisela Beller, Max Schubach, Eik Vettorazzi, Julian Stürznickel, Tim Rolvien, Nadja Ehmke, Alena Delsmann, Franca Genest, Ulrike Krüger, Tomasz Zemojtel, Florian Barvencik, Thorsten Schinke, Franz Jakob, Lorenz C Hofbauer, Stefan Mundlos, Uwe Kornak
Genetic Diagnostics in Routine Osteological Assessment of Adult Low Bone Mass Disorders. The Journal of clinical endocrinology and metabolism 107 (7) (2022)
Elena Tsourdi, Elaine W Yu, Suzanne M Jan de Beur, Matthew T Drake
Vaccination for Coronavirus Disease 2019 (COVID-19) and Relationship to Osteoporosis Care: Current Evidence and Suggested Approaches. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 36 (6) (2021)